Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities.
Immune-mediated inflammatory diseases (IMID) present a group of common and highly disabling chronic conditions that share inflammatory pathways. Several incidence and prevalence studies of IMID during the past decades have reported a considerable variation of the disease occurrence among different populations. Overall, the estimated prevalence of IMID in Western society is 5%-7%. This article provides an overview of studies of the incidence, prevalence, natural history, and comorbidities of IMID.
El-Gabalawy
Hani
H
Arthritis Centre, University of Manitoba, Winnipeg, Manitoba, Canada. elgabalh@cc.umanitoba.ca
Guenther
Lyn C
LC
Bernstein
Charles N
CN
D002318:Cardiovascular Diseases / Q000453:epidemiology; D015897:Comorbidity; D018450:Disease Progression; D005260:Female; D014943:Global Health; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015994:Incidence; D007249:Inflammation / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D015995:Prevalence; D017678:Sex Distribution
D007166:Immunosuppressive Agents